Taberna M - Search Results

1

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma.

Oliva M, Spreafico A, Taberna M, Alemany L, Coburn B, Mesia R, Siu LL. Oliva M, et al. Among authors: taberna m. Ann Oncol. 2019 Jan 1;30(1):57-67. doi: 10.1093/annonc/mdy507. Ann Oncol. 2019. PMID: 30462163 Free PMC article. Review.

2

Natural language processing to identify and characterize spondyloarthritis in clinical practice.

Benavent D, Benavent-Núñez M, Marin-Corral J, Arias-Manjón J, Navarro-Compán V, Taberna M, Salcedo I, Peiteado D, Carmona L, de Miguel E; Savana Research group. Benavent D, et al. Among authors: taberna m. RMD Open. 2024 May 24;10(2):e004302. doi: 10.1136/rmdopen-2024-004302. RMD Open. 2024. PMID: 38796183 Free PMC article.

3

Assessing the Performance of Clinical Natural Language Processing Systems: Development of an Evaluation Methodology.

Canales L, Menke S, Marchesseau S, D'Agostino A, Del Rio-Bermudez C, Taberna M, Tello J. Canales L, et al. Among authors: taberna m. JMIR Med Inform. 2021 Jul 23;9(7):e20492. doi: 10.2196/20492. JMIR Med Inform. 2021. PMID: 34297002 Free PMC article.

4

Late toxicity after radical treatment for locally advanced head and neck cancer.

Taberna M, Rullan AJ, Hierro C, Navarro V, Vázquez S, Lozano A, Vilajosana E, Maños M, Marí A, Viñals J, Mesía R. Taberna M, et al. Oral Oncol. 2015 Aug;51(8):795-9. doi: 10.1016/j.oraloncology.2015.05.002. Epub 2015 Jun 4. Oral Oncol. 2015. PMID: 26051499

5

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.

Mesía R, Vázquez S, Grau JJ, García-Sáenz JA, Lozano A, García C, Carles J, Irigoyen A, Mañós M, García-Paredes B, del Barco E, Taberna M, Escobar Y, Cruz JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Mesía R, et al. Among authors: taberna m. Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):289-96. doi: 10.1016/j.ijrobp.2015.10.019. Epub 2015 Oct 22. Int J Radiat Oncol Biol Phys. 2016. PMID: 26675064 Clinical Trial.

6

Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck.

Linares J, Rullan A, Taberna M, Vazquez S, Mesia R. Linares J, et al. Among authors: taberna m. Oral Oncol. 2016 Apr;55:e4. doi: 10.1016/j.oraloncology.2016.02.006. Epub 2016 Feb 28. Oral Oncol. 2016. PMID: 26924081 No abstract available.

7

Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab.

Montal R, Oliva M, Taberna M, De Avila L, Rovira A, Cos M, Mañós M, Navarro V, Nogués J, Lozano A, Rodríguez L, Vilajosana E, Vázquez S, Mesia R. Montal R, et al. Among authors: taberna m. Clin Transl Oncol. 2016 Nov;18(11):1140-1146. doi: 10.1007/s12094-016-1496-y. Epub 2016 Mar 10. Clin Transl Oncol. 2016. PMID: 26960559

8

Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

Grau JJ, Mesía R, de la Iglesia-Vicente M, Williams ES, Taberna M, Caballero M, Larque AB, de la Oliva J, Cordón-Cardo C, Domingo-Domenech J. Grau JJ, et al. Among authors: taberna m. Oncology. 2016;90(5):267-72. doi: 10.1159/000445118. Epub 2016 Apr 15. Oncology. 2016. PMID: 27077749

9

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location.

Seijas-Tamayo R, Fernández-Mateos J, Adansa Klain JC, Mesía R, Pastor Borgoñón M, Pérez-Ruiz E, Vázquez Fernández S, Salvador Coloma C, Rueda Domínguez A, Taberna M, Martínez-Trufero J, Bonfill Abella T, Vázquez Estévez S, Pollán M, Del Barco Morillo E, Cruz-Hernández JJ. Seijas-Tamayo R, et al. Among authors: taberna m. Clin Transl Oncol. 2016 Nov;18(11):1114-1122. doi: 10.1007/s12094-016-1493-1. Epub 2016 Apr 25. Clin Transl Oncol. 2016. PMID: 27112939

10

Cetuximab as treatment for head and neck cancer patients with a previous liver transplant: report of two cases.

Holguin F, Rubió-Casadevall J, Saigi M, Marruecos J, Taberna M, Tobed M, Maños M, Mesía R. Holguin F, et al. Among authors: taberna m. J Chemother. 2017 Oct;29(5):310-313. doi: 10.1080/1120009X.2016.1187360. Epub 2016 Jul 5. J Chemother. 2017. PMID: 27380218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters